Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Azelis Group NVFRA:2R7 +0.69%81 EV-to-EBIT is 16.77 as of Aug. 10, 2026, which is 3% below its 10-year median of 17.28. GuruFocus rates FRA:2R7 with a GF Score™ of 81/100 and a GF Value™ of €17.31 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,242 Chemicals companies, Azelis Group NV ranks better than 52.98% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Azelis Group NV's Enterprise Value for the quarter that ended in Jun. 2026 was €3,954 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Azelis Group NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €269 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azelis Group NV EV-to-EBIT Related Terms
Azelis Group NV EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Azelis Group NV's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Azelis Group NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azelis Group NV EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Azelis Group NV's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Azelis Group NV's EV-to-EBIT falls into.
Azelis Group NV's current Enterprise Value is €4,510 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Azelis Group NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €269 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azelis Group NV (FRA:2R7) has a EV-to-EBIT of 16.77 as of Aug. 10, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Azelis Group NV and its competitors. This is near median its historical median of 17.28. Over the past decade, Azelis Group NV's EV-to-EBIT has ranged from 10.62 to 56.18. According to the industry distribution chart, Azelis Group NV ranks #584 out of 1242 companies in the Chemicals industry, placing it in the top 47%.
Is Azelis Group NV's EV-to-EBIT too high?
Azelis Group NV's current EV-to-EBIT of 16.77 is near median its 10-year median of 17.28. Over the past 10 years, this metric has ranged from a low of 10.62 to a high of 56.18. The Chemicals industry median EV-to-EBIT is 17.68. Azelis Group NV's value of 16.77 is 5.1% below this industry median. Based on the distribution chart, Azelis Group NV ranks #584 out of 1242 companies in the Chemicals industry, which is above the industry midpoint. Overall, Azelis Group NV has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Azelis Group NV ranks #584 out of 1242 companies for EV-to-EBIT. This puts Azelis Group NV in the upper half of its industry. The industry median EV-to-EBIT is 17.68. Azelis Group NV's value of 16.77 is 5.1% below this benchmark. Historically, Azelis Group NV's own EV-to-EBIT has ranged from 10.62 to 56.18 over the past decade. While the company's 10-year median is 17.28 vs. the industry median of 17.68, Azelis Group NV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.68, based on 1,242 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Azelis Group NV's current EV-to-EBIT of 16.77 is 5.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Azelis Group NV and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Azelis Group NV's current EV-to-EBIT is 16.77, which is near median its own 10-year median of 17.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (FRA:2R7) is currently considered Significantly Undervalued. The stock's GF Value™ is €17.31, compared to a current price of €11.75 — trading 32.1% below its estimated fair value. The current EV-to-EBIT is 16.77, which is near median its 10-year median of 17.28 and 5.1% below the Chemicals industry median of 17.68. Azelis Group NV's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Azelis Group NV (FRA:2R7), the current EV-to-EBIT is 16.77 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azelis Group NV (FRA:2R7) Overvalued in 2026?
Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued.
The current stock price of €11.75 is trading 32.1% below its estimated GF Value™ of €17.31.
GuruFocus considers Azelis Group NV to be Significantly Undervalued.
Key valuation signals for FRA:2R7:
EV-to-EBIT: 16.77 (near median its 10-year median of 17.28)
GF Value™: €17.31 vs. price of €11.75 (32.1% below fair value)
Industry Position: 5.1% below the Chemicals median (#584 of 1242)
No single metric tells the full story. See the FRA:2R7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
81GF Score
Get the complete analysis for FRA:2R7
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2R7 has been successfully added to your 
